Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	-	-	-
Operating Expenses	3.57% 53.70	55.68	55.62	49.05	43.33
Depreciation and Amortization	50.92% 0.851	1.734	0.602	0.354	0.515
Operating Income/Loss	3.57% -53.70	-55.68	-55.62	-49.05	-43.33
Nonoperating Income/Loss	23.81% 8.747	7.065	7.943	7.614	7.075
Income/Loss From Continuing Operations Before Tax	7.55% -44.95	-48.62	-47.68	-41.44	-36.26
Income Tax Expense/Benefit, Deferred	28.21% -0.20	-0.156	-0.224	0.288	0.005
Income Tax Expense/Benefit	30.57% -0.205	-0.157	-0.22	0.29	1.139
Income/Loss From Continuing Operations After Tax	7.67% -44.74	-48.46	-47.46	-41.73	-37.40
Net Income/Loss	7.67% -44.74	-48.46	-47.46	-41.73	-37.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-0.017
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.44% 1.0263	66.00	65.86	65.72	1.7052
Diluted Average Shares	98.44% 1.0263	66.00	65.86	65.72	1.7052
Basic Earnings Per Share	12.33% -0.64	-0.73	-0.72	-0.63	-0.57
Diluted Earnings Per Share	12.33% -0.64	-0.73	-0.72	-0.63	-0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-0.017